SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells (Q39594973)

13 September 2017

title

SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells (English)

1 reference

13 September 2017

0 references

1 reference

Manuela Horndasch

1 reference

13 September 2017

Zoran Culig

series ordinal

1 reference

13 September 2017

publication date

9 February 2011

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

1357-1366

1 reference

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Suppressors of cytokine signaling and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Suppressors of cytokine signalling: SOCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

Perturbations of the AKT signaling pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21353

21 January 2018

Identifiers

DOI

10.1002/PROS.21353

1 reference

13 September 2017

1 reference